32
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Zigzagged Augmentation Index in Diabetes

, , , , , , , , & show all
Pages 657-668 | Received 25 Aug 2008, Accepted 29 Oct 2008, Published online: 10 Dec 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tsuneo Takenaka, Kosuke Uchida, Eriko Kojima, Shiko Gen, Yuri Nodaira, Hitoshi Hoshi, Nobutaka Kato, Hiroshi Takane, Yoichi Ohno & Hiromichi Suzuki. (2011) Amlodipine and Loop Diuretics as the Second Anti-Hypertensive Medication for the Treatment of Hypertension with Chronic Kidney Diseases. Clinical and Experimental Hypertension 33:4, pages 210-215.
Read now

Articles from other publishers (3)

Tsuneo Takenaka, Miyako Kishimoto, Mari Ohta, Osamu Tomonaga & Hiromichi Suzuki. (2017) Sodium–glucose co-transporter type 2 inhibitors reduce evening home blood pressure in type 2 diabetes with nephropathy. Diabetes and Vascular Disease Research 14:3, pages 258-261.
Crossref
Yoshihiko Kanno, Tsuneo Takenaka, Yusuke Watanabe, Tsutomu Inoue, Hiroshi Takane, Yoichi Ohno, Matsuhiko Hayashi & Hiromichi Suzuki. (2014) Paradoxical Distribution of Augmentation Index Level in Chronic Kidney Diseases. Nephrology Research & Reviews 4:2, pages 79-82.
Crossref
Tsuneo Takenaka, Takahiko Sato, Hitoshi Hoshi, Nobutaka Kato, Keita Sueyoshi, Masahiro Tsuda, Yusuke Watanabe, Hiroshi Takane, Yoichi Ohno & Hiromichi Suzuki. (2011) Height Constitutes an Important Predictor of Mortality in End-Stage Renal Disease. Cardiology Research and Practice 2011, pages 1-8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.